Comparative Evaluation of Gilteritinib and Emavusertib in FLT3/KMT2A Mutant AML Cells

Xospata (gilteritinib) - Astellas

emavusertib (CA-4948) - Curis, Dr. Reddy’s

Revuforj (revumenib) - Syndax Pharma

Bechwar J. 1; Bahr S. 1; Fischer M. 2; Scholl S. 1,3; Hochhaus A. 1; Schnetzke U. 1; Fleischmann M. 1

Nov 6, 2025